Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Articles
Is the patient the new KOL?

Is the patient the new KOL?

Danny Stepto addresses the increasing importance of digital channels in changing the stakeholder landscape. The king is dead, long live the king. As patients are encouraged to be more proactive about their healthcare, and are becoming central to their...

Articles
Achieving launch excellence in oncology: adapting to new market realities

Achieving launch excellence in oncology: adapting to new mar...

As the oncology market is becoming increasingly harder to successfully enter, Dr. Simone Seiter and Maneesh Gupta highlight here the new “rules of the game” in achieving oncology launch excellence. Biotechnology and pharmaceutical companies are paying a high price as the oncology market matures and access is increasingly...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more